# Post Transplant Study

> **NCT00395902** · — · COMPLETED · sponsor: **Amgen** · enrollment: 50 (—)

## Conditions studied

- Kidney Tansplant
- Secondary Hyperparathyroidism
- Hyperparathyroidism

## Interventions

- **DRUG:** Sensipar after Post Transplant

## Key facts

- **NCT ID:** NCT00395902
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 50 (—)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395902, "Post Transplant Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00395902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*